U.S. FDA Says Global Drug Safety On Importers’ Shoulders
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA is grappling with the challenges of import safety as the number of foreign-sourced drugs entering the country exceeds FDA's inspection capabilities, and the agency hopes two risk-based draft guidances will increase industry accountability and free up resources for high-risk inspections
You may also be interested in...
FDA May Require Drug Importers To Verify Product Quality
Public meeting will solicit stakeholder comments on how FDASIA-mandated import regulations should be implemented as the expedited entry program reemerges.
FDA Supply Chain Initiative And Foreign Inspection Increases Funded Under White House ’10 Budget
The $3.2 billion U.S. FDA budget proposed May 7 by the Obama administration includes a number of proposals aimed at ensuring global drug safety, including a $166 million initiative for improving supply chain safety for medical products
FDA Supply Chain Initiative And Foreign Inspection Increases Funded Under White House ’10 Budget
The $3.2 billion U.S. FDA budget proposed May 7 by the Obama administration includes a number of proposals aimed at ensuring global drug safety, including a $166 million initiative for improving supply chain safety for medical products